Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
VVOS
$0.30
-11.94%
VVOS · Vivos Therapeutics, Inc.
$0.30
-0.04 (-11.94%)
At close · Aug 17
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.91M
Shares
20.12M
All earnings calls
Earnings call · FY2020 Q4
Vivos Therapeutics, Inc. Q4 FY2020 Earnings Call
Vivos Therapeutics, Inc. Q4 FY2020 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$3.31M
Gross margin · derived Q4
81.3%
Net income · derived Q4
-$6.25M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 25, 2021 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 25, 2021 · complete as-filed document